In millions, except per share data Years ended December 31 |
08 |
07 |
||||
Assets |
||||||
Current assets |
||||||
Cash and cash equivalents |
$ |
2,183.9 |
$ |
2,767.9 |
||
Investments available-for-sale, at fair value |
2,652.8 |
3,726.3 |
||||
Other invested assets, current |
23.6 |
40.3 |
||||
Premium and self-funded receivables |
3,042.9 |
2,870.1 |
||||
Other receivables |
1,546.7 |
1,162.2 |
||||
Income tax receivable |
159.9 |
0.9 |
||||
Securities lending collateral |
529.0 |
854.1 |
||||
Deferred tax assets, net |
779.0 |
559.6 |
||||
Other current assets |
1,212.2 |
1,050.4 |
||||
Total current assets |
12,130.0 |
13,031.8 |
||||
Long-term investments available-for-sale, at fair value |
11,839.1 |
13,962.4 |
||||
Other invested assets, long-term |
703.2 |
752.9 |
||||
Property and equipment, net |
1,054.5 |
995.9 |
||||
Goodwill |
13,461.3 |
13,435.4 |
||||
Other intangible assets |
8,827.2 |
9,220.8 |
||||
Other noncurrent assets |
387.9 |
660.8 |
||||
Total assets |
$ |
48,403.2 |
$ |
52,060.0 |
||
Liabilities and shareholders’ equity |
||||||
Liabilities |
||||||
Current liabilities |
||||||
Policy liabilities |
||||||
Medical claims payable |
$ |
6,184.7 |
$ |
5,788.0 |
||
Reserves for future policy benefits |
64.5 |
63.7 |
||||
Other policyholder liabilities |
1,626.8 |
1,832.2 |
||||
Total policy liabilities |
7,876.0 |
7,683.9 |
||||
Unearned income |
1,087.7 |
1,114.6 |
||||
Accounts payable and accrued expenses |
2,856.5 |
2,909.6 |
||||
Security trades pending payable |
5.8 |
50.6 |
||||
Securities lending payable |
529.0 |
854.1 |
||||
Short-term borrowings |
98.0 |
– |
||||
Current portion of long-term debt |
909.7 |
20.4 |
||||
Other current liabilities |
1,657.6 |
1,755.0 |
||||
Total current liabilities |
15,020.3 |
14,388.2 |
||||
Long-term debt, less current portion |
7,833.9 |
9,023.5 |
||||
Reserves for future policy benefits, noncurrent |
664.7 |
661.9 |
||||
Deferred tax liability, net |
2,098.9 |
3,004.4 |
||||
Other noncurrent liabilities |
1,353.7 |
1,991.6 |
||||
Total liabilities |
26,971.5 |
29,069.6 |
||||
Shareholders’ equity |
||||||
Common stock, par value $0.01, shares authorized 900,000,000; shares issued and outstanding: 503,230,575 and 556,212,039 |
5.0 |
5.6 |
||||
Additional paid-in capital |
16,843.0 |
18,441.1 |
||||
Retained earnings |
5,479.4 |
4,387.6 |
||||
Accumulated other comprehensive (loss) income |
(895.7 |
) |
156.1 |
|||
Total shareholders’ equity |
21,431.7 |
22,990.4 |
||||
Total liabilities and shareholders’ equity |
$ |
48,403.2 |
$ |
52,060.0 |
||
The information presented above should be read in conjunction with the audited financial statements and accompanying notes included in WellPoint’s 2008 Annual Report on Form 10-K. |
©2009 WellPoint, Inc. All Rights Reserved. Legal Notice | Privacy Policy